Azaindolylidene derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
US7371862B2 · kind B2 · utility
20Cited by
0References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 11, 2005 |
| Grant date | May 13, 2008 |
| Priority date | — |
| Expiry date | Nov 19, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to compounds of the formulaor pharmaceutically acceptable salts, prodrug, solvate or optical isomer thereof, pharmaceutical compositions containing same and use thereof for treating diseases linked to disregulated cell proliferation or to disregulated protein kinase.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.